NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
29 hedge funds and large institutions have $379K invested in Navidea Biopharmaceuticals Inc. in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
4
Closed
4
Calls
$14K
Puts
$47K
Net Calls
-$33K
Net Calls Change
-$19K
Top Buyers
Top Sellers
1 |
WS
1
Wedbush Securities
Los Angeles,
California
|
$0 |
2 |
VF
2
Virtu Financial
New York
|
$13K |
3 |
3
Jane Street
New York
|
$0 |
4 |
ACM
4
Allred Capital Management
Dallas,
Texas
|
$8K |
5 |
5
Citigroup
New York
|
$1K |